Page last updated: 2024-08-22

improsan and Granulocytic Leukemia, Chronic

improsan has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hirano, M; Kakizawa, H; Kawashima, K; Miura, M; Morita, A; Nishiwaki, H; Ohno, R; Uetani, T; Yamada, K	1

Trials

1 trial(s) available for improsan and Granulocytic Leukemia, Chronic

Article	Year
Treatment of chronic myelogenous leukemia with 3,3'-iminodi-1-propanol, dimethanesulfonate (ester), p-toluenesulfonate (NSC-140117) given orally. Cancer chemotherapy reports, 1972, Volume: 56, Issue:3 Topics: Administration, Oral; Adult; Antineoplastic Agents; Female; Granulocytes; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mesylates; Middle Aged; Remission Induction; Treatment Outcome	1972

Article

Year

Treatment of chronic myelogenous leukemia with 3,3'-iminodi-1-propanol, dimethanesulfonate (ester), p-toluenesulfonate (NSC-140117) given orally.

Cancer chemotherapy reports, 1972, Volume: 56, Issue:3

Topics: Administration, Oral; Adult; Antineoplastic Agents; Female; Granulocytes; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mesylates; Middle Aged; Remission Induction; Treatment Outcome

1972